Volume 11; Issue 3

Main
Targeted Oncology
Volume 11; Issue 3

Targeted Oncology

Volume 11; Issue 3

1

Acceleration of Proteinuria without Significant Impact on Renal Function and Its Protection by Angiotensin II Receptor Blocker in Rats Treated with Axitinib

Imai, Satoshi, Miyake, Hideaki, Fujisawa, Masato

Journal:

Targeted Oncology

Year:

2016

Language:

english

File:

PDF, 890 KB

english, 2016

2

Changes in Renal Function of Patients with Metastatic Renal Cell Carcinoma During Treatment with Molecular-Targeted Agents

Miyake, Hideaki, Muramaki, Mototsugu, Imai, Satoshi, Harada, Ken-ichi, Fujisawa, Masato

Journal:

Targeted Oncology

Year:

2016

Language:

english

File:

PDF, 554 KB

english, 2016

3

Heterodimeric Bispecific Single Chain Variable Fragments (scFv) Killer Engagers (BiKEs) Enhance NK-cell Activity Against CD133+ Colorectal Cancer Cells

Schmohl, J. U., Gleason, M. K., Dougherty, P. R., Miller, J. S., Vallera, D. A.

Journal:

Targeted Oncology

Year:

2016

Language:

english

File:

PDF, 1.41 MB

english, 2016

4

Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis

Massari, Francesco, Ciccarese, Chiara, Caliò, Anna, Munari, Enrico, Cima, Luca, Porcaro, Antonio Benito, Novella, Giovanni, Artibani, Walter, Sava, Teodoro, Eccher, Albino, Ghimenton, Claudio, Bertold

Journal:

Targeted Oncology

Year:

2016

Language:

english

File:

PDF, 1007 KB

english, 2016

5

RareRASMutations in Metastatic Colorectal Cancer Detected During RoutineRASGenotyping Using Next Generation Sequencing

Harlé, Alexandre, Filhine-Tresarrieu, Pierre, Husson, Marie, Boidot, Romain, Rouyer, Marie, Dubois, Cindy, Leroux, Agnès, Merlin, Jean-Louis

Journal:

Targeted Oncology

Year:

2016

Language:

english

File:

PDF, 576 KB

english, 2016

6

Systematic Review of the Side Effects Associated With Anti-HER2-Targeted Therapies Used in the Treatment of Breast Cancer, on Behalf of the EORTC Quality of Life Group

Sodergren, Samantha C., Copson, Ellen, White, Alice, Efficace, Fabio, Sprangers, Mirjam, Fitzsimmons, Deborah, Bottomley, Andrew, Johnson, Colin D.

Journal:

Targeted Oncology

Year:

2016

Language:

english

File:

PDF, 527 KB

english, 2016

7

Dose-Dense Temozolomide in Patients withMGMT-Silenced Chemorefractory Colorectal Cancer

Pietrantonio, Filippo, de Braud, Filippo, Milione, Massimo, Maggi, Claudia, Iacovelli, Roberto, Dotti, Katia Fiorella, Perrone, Federica, Tamborini, Elena, Caporale, Marta, Berenato, Rosa, Leone, Gior

Journal:

Targeted Oncology

Year:

2016

Language:

english

File:

PDF, 1.17 MB

english, 2016

8

Afatinib, an Irreversible EGFR Family Inhibitor, Shows Activity Toward Pancreatic Cancer Cells, Alone and in Combination with Radiotherapy, Independent ofKRASStatus

Huguet, Florence, Fernet, Marie, Giocanti, Nicole, Favaudon, Vincent, Larsen, Annette K.

Journal:

Targeted Oncology

Year:

2016

Language:

english

File:

PDF, 1.37 MB

english, 2016

9

A Review of Clinical Studies and Practical Guide for the Administration of Triplet Chemotherapy Regimens with Bevacizumab in First-line Metastatic Colorectal Cancer

Loupakis, Fotios, Stein, Alexander, Ychou, Marc, Hermann, Frank, Salud, Antonieta, Österlund, Pia

Journal:

Targeted Oncology

Year:

2016

Language:

english

File:

PDF, 862 KB

english, 2016

10

Targeted Therapies for the Treatment of Brain Metastases in Solid Tumors

Bohn, Jan-Paul, Pall, Georg, Stockhammer, Guenther, Steurer, Michael

Journal:

Targeted Oncology

Year:

2016

Language:

english

File:

PDF, 483 KB

english, 2016

11

An Adaptive Study to Determine the Optimal Dose of the Tablet Formulation of the PARP Inhibitor Olaparib

Mateo, J., Moreno, V., Gupta, A., Kaye, S. B., Dean, E., Middleton, M. R., Friedlander, M., Gourley, C., Plummer, R., Rustin, G., Sessa, C., Leunen, K., Ledermann, J., Swaisland, H., Fielding, A., Ban

Journal:

Targeted Oncology

Year:

2016

Language:

english

File:

PDF, 511 KB

english, 2016

12

Dabrafenib plus Trametinib: a Review in Advanced Melanoma with aBRAFV600Mutation

Dhillon, Sohita

Journal:

Targeted Oncology

Year:

2016

Language:

english

File:

PDF, 754 KB

english, 2016

13

Phase 1 Study of Monotherapy with KHK2866, an Anti-Heparin-Binding Epidermal Growth Factor-Like Growth Factor Monoclonal Antibody, in Patients with Advanced Cancer

Sarantopoulos, John, Mita, Monica M., Birrer, Michael J., Cranmer, Lee D., Campos, Luis T., Zhang, Xiaoping, Bristow, Penelope, Kaito, Hidekuni, Strout, Vincent, Camacho, Luis H.

Journal:

Targeted Oncology

Year:

2016

Language:

english

File:

PDF, 457 KB

english, 2016

14

Erratum to: Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy

Despierre, Evelyn, Vergote, Ignace, Anderson, Ryan, Coens, Corneel, Katsaros, Dionyssios, Hirsch, Fred R., Boeckx, Bram, Varella-Garcia, Marileila, Ferrero, Annamaria, Ray-Coquard, Isabelle, Green, Jo

Journal:

Targeted Oncology

Year:

2016

Language:

english

File:

PDF, 244 KB

english, 2016